Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ELTX holding history

Elicio Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELTX overviewAll 13F holders of ELTXFull Q2 2026 holdings

Shares (Q2 2026)
40,419
Value
$158.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ELTX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202640,419$158.0K<0.1%+6,650+19.7%AddedHolders
Q1 202633,769$361.0K<0.1%+1,753+5.5%AddedHolders
Q4 202532,016$254.8K<0.1%+24,997+356.1%AddedHolders
Q3 20257,019$76.8K<0.1%+996+16.5%AddedHolders
Q2 20256,023$46.5K<0.1%−15,175−71.6%ReducedHolders
Q1 202521,198$130.6K<0.1%+21,181+124,594.1%AddedHolders
Q4 202417$87<0.1%−831−98.0%ReducedHolders
Q3 2024848$4.27K<0.1%+831+4,888.2%AddedHolders
Q2 202417$70<0.1%+1+6.3%AddedHolders
Q1 202416$122<0.1%00.0%UnchangedHolders
Q4 202316$133<0.1%00.0%UnchangedHolders
Q3 202316$135<0.1%−629−97.5%ReducedHolders
Q2 2023645$6.13K<0.1%−804−55.5%ReducedConverted for a 1-for-10 splitHolders
Q1 202314,492$8.41K<0.1%+4,573+46.1%AddedHolders
Q4 20229,919$8.04K<0.1%+2,679+37.0%AddedHolders
Q3 20227,240$7.00K<0.1%−3,729−34.0%ReducedHolders
Q2 202210,969$12.0K<0.1%+10,503+2,253.9%AddedHolders
Q1 2022466$1.00K<0.1%−8,071−94.5%ReducedHolders
Q4 20218,537$25.0K<0.1%+8,537NewHolders
Q3 20210$00.0%−217−100.0%Sold outHolders
Q2 2021217$3.00K<0.1%−1,413−86.7%ReducedHolders
Q1 20211,630$29.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.